- Home
- Structural Heart Disease
Structural Heart Disease
Severe Aortic Stenosis: Stratifying Patients for Lifetime Management
- 1 EBAC
Published:
Learning objectives
- Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
- Summarise clinical evidence for TAVI in low surgical risk patients
- Recall different guideline recommendations for SAVR and TAVI approaches
- Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
Hypertrophic Cardiomyopathy in Review: ESC–HFA 2022 & How to Differentiate HCM From Its Phenocopies
- 0.50 AMA PRA Credit
Published:
Learning objectives
- Recall the efficacy and safety of existing HCM treatments and summarise results from ongoing trials with experimental treatments
- Differentiate the signs and symptoms of HCM from other conditions that frequently mask, or mimic the disease and in the presence of comorbidities
Hypertrophic Cardiomyopathy in Review: Highlights of ACC 2022
- 0.25 AMA PRA Credit
Published:
Learning objectives
- Recall the efficacy and safety of existing HCM treatments and summarise results from ongoing trials with experimental treatments
Getting it Right First Time in Severe Aortic Stenosis - Key insights for Long Term Success
- 1 EBAC
Published:
Learning objectives
- Recall current and predicted trends in TAVI with respect to preserving coronary access
- Consider determining factors for choosing valves in low risk populations
- Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
Optimising Outcomes For The Tavi Patient: Key Considerations For First Valve Choice And Implantation Techniques
Published:
Learning objectives
- Recall the latest data showing why durability and hemodynamics matter for initial valve selection
- Discuss the latest techniques to help achieve optimal outcomes for patients with longer life expectancy
- Review TAVI cases that highlight procedure optimisation with the Evolut pro+ platform
Transcatheter Interventions Online - Session 3.4: Debates
- 1 EBAC
Published:
Learning objectives
- Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
- Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
- Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
- Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
- Discuss the need for gender-specific trials and renal denervation
